Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges

Circulating tumor DNA (ctDNA) has emerged as a biomarker with wide-ranging applications in cancer management. While its role in guiding precision medicine in certain tumors via noninvasive detection of susceptibility and resistance alterations is now well established, recent evidence has pointed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanz-Garcia, Enrique, Zhao, Eric, Bratman, Scott V., Siu, Lillian L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791609/
https://www.ncbi.nlm.nih.gov/pubmed/35080978
http://dx.doi.org/10.1126/sciadv.abi8618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791609/
https://www.ncbi.nlm.nih.gov/pubmed/35080978
http://dx.doi.org/10.1126/sciadv.abi8618

Ejemplares similares